Viewing Study NCT02614066


Ignite Creation Date: 2025-12-24 @ 4:41 PM
Ignite Modification Date: 2026-03-11 @ 11:58 AM
Study NCT ID: NCT02614066
Status: COMPLETED
Last Update Posted: 2024-11-19
First Post: 2015-11-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
Sponsor:
Organization: